detectnet
(copper Cu 64 Dotatate)CURIUM US LLC
Usage: Detectnet is indicated for use with positron emission tomography (PET) to localize somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.
7 results
everolimus
(Everolimus)ENDO USA, Inc.Usage: Everolimus Tablets are indicated for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer; adults with progressive neuroendocrine tumors (pancreatic, gastrointestinal, or lung origin); advanced renal cell carcinoma after prior treatment failure; renal angiomyolipoma associated with tuberous sclerosis complex; and subependymal giant cell astrocytoma in TSC patients.ga-68-dotatoc
(EDOTREOTIDE GALLIUM GA-68)UIHC – P E T Imaging CenterUsage: Ga 68 DOTATOC Injection is indicated for use with PET to localize somatostatin receptor positive neuroendocrine tumors (NETs) in both adult and pediatric patients.kit for the preparation of indium in 111 pentetreotide
(Indium In-111 Pentetreotide)Sun Pharmaceutical Industries, Inc.Usage: Indium In-111 pentetreotide injection is used for scintigraphic localization of primary and metastatic neuroendocrine tumors that express somatostatin receptors.netspot
(68Ga-DOTATATE)Advanced Accelerator Applications USA, IncUsage: NETSPOT, after radiolabeling with gallium-68, is indicated for positron emission tomography (PET) to localize somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.octreoscan
(Indium In -111 Pentetreotide)Curium US LLCUsage: Octreoscan is used for scintigraphic localization of primary and metastatic neuroendocrine tumors that express somatostatin receptors, following radiolabeling.somatuline depot
(lanreotide acetate)Ipsen Biopharmaceuticals, Inc.Usage: SOMATULINE DEPOT is indicated for long-term treatment of acromegaly, unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and carcinoid syndrome in adults. It aims to normalize growth hormone levels, improve progression-free survival in GEP-NETs, and reduce the need for short-acting somatostatin analog rescue therapy in carcinoid syndrome.